US 12202880
HLA engineering methods and compositions for treatment of autoimmunity
granted A61KA61K35/28A61K38/00
Quick answer
US patent 12202880 (HLA engineering methods and compositions for treatment of autoimmunity) held by The Regents of the University of Colorado expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K35/28, A61K38/00, A61K40/10, A61K40/22